세르비에 | 좌장: 백상홍 (가톨릭의대) | |
17:10-17:40 | Managing Heart Failure Patients in Day-to-Day Practice, How to Keep the Patient out of the Hospital | Christoph Maack (University Clinic Würzburg, Germany) |
17:40-17:50 | Q & A | |
BMS "Recent Advances in Improving Patient Care with Apixaban" | 좌장: 최동주 (서울의대) | |
17:50-18:10 | What Is the Role of Apixaban in Managing the ‘Fragile‘ AF Patient? | 정진옥 (충남의대) |
18:10-18:30 | The Patients in Focus: AF Patients with Concomitant Heart Disease | 김응주 (고려의대) |
베링거인겔하임 | 좌장: 최동주 (서울의대) | |
17:10-17:30 | What’s New on the Ideal Duo, Idarucizumab and Dabigatran in 2017? | 정욱진 (가천의대) |
17:30-17:50 | Heart Failure in Diabetes: Exploring Benefit of Empagliflozin in Patients with HF | 강석민 (연세의대) |
MSD | 좌장: 김영대 (동아의대) | |
17:50-18:15 | Why Do We Consider Ezetimibe/Atorvastatin FDC in ACS/CHD Patients | 이주희 (충북의대) |
18:15-18:30 | Q & A |